Last reviewed · How we verify
Mepivacaine with Fentanyl — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Mepivacaine with Fentanyl (Mepivacaine with Fentanyl) — University Health Network, Toronto.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mepivacaine with Fentanyl TARGET | Mepivacaine with Fentanyl | University Health Network, Toronto | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mepivacaine with Fentanyl CI watch — RSS
- Mepivacaine with Fentanyl CI watch — Atom
- Mepivacaine with Fentanyl CI watch — JSON
- Mepivacaine with Fentanyl alone — RSS
Cite this brief
Drug Landscape (2026). Mepivacaine with Fentanyl — Competitive Intelligence Brief. https://druglandscape.com/ci/mepivacaine-with-fentanyl. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab